Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Renal Transplant Rejection: early-phase trial registry
1 of 3 indexed Renal Transplant Rejection trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Renal Transplant Rejection: 3 US clinical trials tracked, 1 recruiting.
Renal Transplant Rejection is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is E. Steve Woodle, running 1 of these trials.
Enrollment posture brief
Registry condition renal-transplant-rejection
OPEN 1 | RECR 33% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Renal Transplant Rejection lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Renal Transplant Rejection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Renal Transplant Rejection is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
Jeffrey Veale, MD
NCT03707262
VIRTUUS Children's Study
Children's Hospital of Philadelphia
NCT03719339
Belimumab Impacting Transplant Eligibility
E. Steve Woodle
NCT02500251
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Renal Transplant Rejection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Renal Transplant Rejection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Renal Transplant Rejection page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Renal Transplant Rejection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- E. Steve Woodle sponsors the most Renal Transplant Rejection trials on record, review their full trial history before evaluating a specific study. See E. Steve Woodle's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Renal Transplant Rejection condition card totals 3 registered trials; most-linked intervention Plasmapheresis; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.